These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 24418164

  • 1. Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study.
    Botto GL, Ricci RP, Bénézet JM, Nielsen JC, De Roy L, Piot O, Quesada A, Quaglione R, Vaccari D, Garutti C, Vainer L, Kozák M, PreFER MVP Investigators.
    Heart Rhythm; 2014 Jun; 11(6):992-1000. PubMed ID: 24418164
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs.
    Sweeney MO, Ellenbogen KA, Casavant D, Betzold R, Sheldon T, Tang F, Mueller M, Lingle J, Marquis MVP Download Investigators.
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):811-7. PubMed ID: 16101620
    [Abstract] [Full Text] [Related]

  • 4. Randomized pilot study of a new atrial-based minimal ventricular pacing mode in dual-chamber implantable cardioverter-defibrillators.
    Sweeney MO, Shea JB, Fox V, Adler S, Nelson L, Mullen TJ, Belk P, Casavant D, Sheldon T.
    Heart Rhythm; 2004 Jul; 1(2):160-7. PubMed ID: 15851147
    [Abstract] [Full Text] [Related]

  • 5. Managed ventricular pacing vs. conventional dual-chamber pacing for elective replacements: the PreFER MVP study: clinical background, rationale, and design.
    Quesada A, Botto G, Erdogan A, Kozak M, Lercher P, Nielsen JC, Piot O, Ricci R, Weiss C, Becker D, Wetzels G, De Roy L, PreFER MVP Investigators.
    Europace; 2008 Mar; 10(3):321-6. PubMed ID: 18308753
    [Abstract] [Full Text] [Related]

  • 6. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias.
    Funck RC, Boriani G, Manolis AS, Püererfellner H, Mont L, Tukkie R, Pisapia A, Israel CW, Grovale N, Grammatico A, Padeletti L, MINERVA Study Group.
    Am Heart J; 2008 Sep; 156(3):445-51. PubMed ID: 18760124
    [Abstract] [Full Text] [Related]

  • 7. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
    Padeletti L, Pürerfellner H, Mont L, Tukkie R, Manolis AS, Ricci R, Inama G, Serra P, Scheffer MG, Martins V, Warman EN, Vimercati M, Grammatico A, Boriani G, MINERVA Investigators.
    Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
    [Abstract] [Full Text] [Related]

  • 8. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL, Dual Chamber and VVI Implantable Defibrillator trial investigators.
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [Abstract] [Full Text] [Related]

  • 9. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.
    Boriani G, Tukkie R, Manolis AS, Mont L, Pürerfellner H, Santini M, Inama G, Serra P, de Sousa J, Botto GL, Mangoni L, Grammatico A, Padeletti L, MINERVA Investigators.
    Eur Heart J; 2014 Sep 14; 35(35):2352-62. PubMed ID: 24771721
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study.
    Chen S, Chen K, Tao Q, Zheng L, Shen F, Wu S, Fan J, Xu G, Wang L, Zhou X, Zhang S, COMPARE Study Investigators.
    Europace; 2014 Nov 14; 16(11):1595-602. PubMed ID: 24706091
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial.
    Boriani G, Pieragnoli P, Botto GL, Puererfellner H, Mont L, Ziacchi M, Manolis AS, Gulizia M, Tukkie R, Landolina M, Ricciardi G, Cicconelli M, Grammatico A, Biffi M.
    Europace; 2019 Apr 01; 21(4):636-644. PubMed ID: 30649270
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The value of DDD pacing in patients with an implantable cardioverter defibrillator.
    Geelen P, Lorga Filho A, Chauvin M, Wellens F, Brugada P.
    Pacing Clin Electrophysiol; 1997 Jan 01; 20(1 Pt 2):177-81. PubMed ID: 9121985
    [Abstract] [Full Text] [Related]

  • 18. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy.
    Lucon A, Palud L, Pavin D, Donal E, Behar N, Leclercq C, Mabo P, Daubert JC.
    Arch Cardiovasc Dis; 2013 Jan 01; 106(6-7):373-81. PubMed ID: 23806305
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.